DB1976 hydrochloride
目录号 : GC39628DB1976 hydrochloride是一种有效的转录因子 PU.1 抑制剂。DB1976 hydrochloride在体外可有效抑制 PU.1 结合(IC50 为 10 nM),并强烈抑制 PU.1/DNA 复合物(具有高 DB1976-λB 亲和力,KD 为 12 nM)。DB1976 hydrochloride具有诱导细胞凋亡的作用 。
Cas No.:2369663-93-2
Sample solution is provided at 25 µL, 10mM.
DB1976 hydrochloride is a efficacious transcription factor PU.1 inhibitor. DB1976 dihydrochloride potently inhibits PU.1 binding (IC50 of 10 nM) and strongly inhibits the PU.1/DNA complex (with high DB1976-λB affinity, KD of 12 nM) in vitro. DB1976 dihydrochloride has apoptosis-inducing effect[1] [4].
DB1976 hydrochloride(0.1-100 mM,48h) led to decrease in the growth of PU.1 URE–/– AML cells (IC50: 105 μM); After DB1976(25uM,24h) treatment, PU.1 was lentivirally expressed in MOLM13 cells, and it was observed that the cytotoxic effects of the compound were rescued and cell viability was increased after treatment with DB1976[1].
DB1976 hydrochloride (5 mg/kg/day,28days)exposure decreased the interstitial, sub-epicardial and perivascular fibrosis induced by Ang-II in the atrial tissue[2]. DB1976 (5 mg/kg/day,28days)effectively attenuated Ang-II-induced increase in the number of atrial fibroblasts and reduced the expression of PCNA, α-SMA, SMemb, ED-A fibronectin, and DDR2 in vitro and in vivo[2]. In an asthma model, DB1976 (1 mg/kg and 2.5 mg/kg,5 days per week for 3 weeks) increased airway eosinophils and reduced small airway collagen deposition but had no effect on the number of mucus-secreting cells[3].
References:
[1]. Antony-Debré I, et al. Pharmacological inhibition of the transcription factor PU.1 in leukemia. J Clin Invest. 2017 Dec 1;127(12):4297-4313.
[2]. Hu J, et al. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation. J Cell Mol Med. 2021 Jul;25(14):6746-6759.
[3]. Tu, X., Gomez, H.M., Kim, R.Y. et al. Airway and parenchyma transcriptomics in a house dust mite model of experimental asthma. Respir Res 24, 32 (2023).
[4].Stephens DC, Kim HM, Kumar A, Farahat AA, Boykin DW, Poon GM. Pharmacologic efficacy of PU.1 inhibition by heterocyclic dications: a mechanistic analysis. Nucleic Acids Res. 2016 May 19;44(9):4005-13.
DB1976 hydrochloride是一种有效的转录因子 PU.1 抑制剂。DB1976 hydrochloride在体外可有效抑制 PU.1 结合(IC50 为 10 nM),并强烈抑制 PU.1/DNA 复合物(具有高 DB1976-λB 亲和力,KD 为 12 nM)。DB1976 hydrochloride具有诱导细胞凋亡的作用[1] [4]。
DB1976 hydrochloride(0.1-100 mM,48h)使PU.1 URE–/– AML细胞生长减少(IC50:105 μM);DB1976(25 uM,24h)处理后,PU.1 URE–/– AML细胞出现凋亡(annexin-V+PI–)[1]。
DB1976 hydrochloride(5mg/kg/day,28天)暴露减少了心房组织中由血管紧张素Ⅱ诱导的间质、心外膜下和血管周围纤维化。DB1976 有效减少Ang-II诱导的心房成纤维细胞的数量增加,并降低体内和体外 PCNA、α-SMA、SMemb 和 ED-A 纤连蛋白和 DDR2 的表达[2]。在哮喘模型中,DB1976(1 mg/kg 和 2.5 mg/kg,每周 5 天,持续 3 周)增加了气道嗜酸性粒细胞,减少了小气道胶原沉积,但对粘液分泌细胞的数量没有影响l[3]。
Cell experiment [1]: | |
Cell lines | URE–/–AML cells;HEK293 cells. |
Preparation Method | PU.1 URE+/–Msh2–/– cells were treated with DB1976(0.1-100mM) for 48 hours. HEK293 cells were treated with DB1976(25μM) for 24 hours. |
Reaction Conditions | PU.1 URE–/–AML cells: (0.1-100) mM,48h;PU.1-negative HEK293 cells:25 μM,24h. |
Applications | The IC50 value of DB1976 dihydrochloride in PU.1-negative HEK293 cells is 2.4 μM;DB1976 dihydrochloride treatment significantly inhibited the growth of PU.1 URE-/-AML cells (IC50 of 105 μM), whereas it had less effect on normal hematopoietic cells (IC50 of 334 μM). |
Animal experiment [2]: | |
Animal models | PU.1 Inhibition Model |
Preparation Method | C57BL/6 mice were administered with Ang-II+ DB 1976 (5 mg/day/kg) by intraperitoneal injection once a day for 28 days. |
Dosage form | 5 mg/day/kg;28 days;ip. |
Applications | DB1976 exposure decreased the interstitial, sub-epicardial and perivascular fibrosis induced by Ang-II in the atrial tissue. |
References: [1].Antony-Debré I, et al. Pharmacological inhibition of the transcription factor PU.1 in leukemia. J Clin Invest. 2017 Dec 1;127(12):4297-4313 [2].Hu J, et al. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation. J Cell Mol Med. 2021 Jul;25(14):6746-6759.. |
Cas No. | 2369663-93-2 | SDF | |
Canonical SMILES | N=C(C1=CC=C2N=C(C3=CC=C(C4=NC5=CC=C(C(N)=N)C=C5N4)[Se]3)NC2=C1)N.[H]Cl.[H]Cl | ||
分子式 | C20H18Cl2N8Se | 分子量 | 520.28 |
溶解度 | DMSO : 62.5 mg/mL (120.13 mM; Need ultrason); H20 : 18.33 mg/mL (35.23 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.922 mL | 9.6102 mL | 19.2204 mL |
5 mM | 0.3844 mL | 1.922 mL | 3.8441 mL |
10 mM | 0.1922 mL | 0.961 mL | 1.922 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet